Taylor Woodrow PLC
30 May 2007
Form TR-1 with annex. FSA Version 2.1 updated April 2007
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
The company has received an amended Form TR-1 as set out below which supersedes
the TR-1 released on 29 May 2007, at 16.56
1. Identity of the issuer or the underlying issuer of Taylor Woodrow plc
existing shares to which voting rights are attached:
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights yes
An acquisition or disposal of financial instruments which may no
result in the acquisition of shares already issued to which
voting rights are attached
An event changing the breakdown of voting rights no
Other (please specify):______________ no
3. Full name of person(s) subject to notification Norman Brian Montague Askew
obligation: (Taylor Woodrow plc Chairman and proxy holder)
4. Full name of shareholder(s) (if different from Shareholders appointing Norman Brian Montague
3): Askew as Proxy
5. Date of transaction (and date on which the
threshold is crossed or reached if different): 29 May 2007
6. Date on which issuer notified: 30 May 2007
7. Threshold(s) that is/are crossed or reached: 61%
8: Notified Details
A: Voting rights attached to shares
Class/type of Situation previous to the Resulting situation after the triggering transaction
shares triggering transaction
Number of Number of Number of Number of voting rights Percentage of voting
If possible use shares voting shares rights
ISIN code rights
Direct Indirect Direct Indirect
Ordinary shares 9,974 9,974 359,956,892 9,974 359,946,918 0.0017 61.83
(below 3%) (below 3%
ISIN:
GB0008782301
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ No. of voting rights that Percentage of
instrument conversion period/ may be acquired (if the voting rights
date instrument exercised/
converted)
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights Percentage of voting rights
359,956,892 61.83
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable:
N/A
Proxy Voting:
10. Name of proxy holder: Norman Brian Montague Askew
(Chairman of Taylor Woodrow plc)
11. Number of voting rights proxy holder will cease
to hold: 359,946,918
12. Date on which proxy holder will cease to hold These voting rights were being held by Norman Brian
voting rights: Montague Askew (Chairman of Taylor Woodrow plc)
pursuant to proxies received for the purposes of an
Extraordinary General Meeting held on 29 May 2007.
The proxies expired and the voting rights lapsed
immediately upon the conclusion of the Extraordinary
General Meeting.
13. Additional information: When the proxies expired 61.83% of voting rights
returned to the shareholders that appointed Norman
Brian Montague Askew as their proxy.
14 Contact name: Richard Morbey
(Group Company Secretary)
15. Contact telephone number: +44 (0)121 600 8540
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange LEAFSEDEAXEFE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.